Elekta divests its Anatomic Pathology Information System

Elekta divests its Anatomic Pathology Information System

 

Elekta AB (publ) today announced it has divested its Anatomic Pathology
Information System business, marketed under the brand name PowerPath®, a
software line that manages workflow for laboratories offering surgical
pathology, cytology, dermatopathology and autopsy services.

The consideration amounts to SEK 225 M, through an asset purchase
structure on a cash and debt-free basis. The buyer is Sunquest
Information Systems, Inc., a US based company providing closely related
diagnostic IT solutions. During fiscal year 2010/11 the Pathology
Information System generated revenues of approximately SEK 80 M and EBIT
of SEK 19 M with 44 employees in the U.S. During the past ten years the
organic growth rate has been modest.

“The PowerPath product line came to Elekta as part of the acquisition of
IMPAC Medical Systems Inc. in 2005. PowerPath is clearly a leading brand
in its sector with an impressive customer list of prestigious
institutions. However, the synergies between PowerPath and Elekta have
been limited and we expect that PowerPath will have good prospects with
Sunquest, given their more complimentary business”, said Tomas Puusepp,
President and CEO of Elekta.

The transaction is expected to result in a capital gain of approximately
SEK 170 M before tax and to add approximately SEK 1.10 to earnings per
share in Elekta's fiscal year 2011/12.

For questions, please contact:

Håkan Bergström, CFO, Elekta AB (publ)
+46 8 587 25 547, hakan.bergstrom@elekta.com

Stina Thorman, Vice President Corporate Communications, Elekta AB (publ)
+46 8 587 25 437, stina.thorman@elekta.com

Johan Andersson Melbi, Investor Relations Manager, Elekta AB (publ)
+46 702 100 451,
johan.anderssonmelbi@elekta.com (johan.anderssonmelbi@elekta.com)

 

The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial
Instruments Trading Act. The information was published at 08.00 CET on
October 3, 2011.

About Elekta

Elekta is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The company
develops sophisticated, state-of-the-art tools and treatment planning
systems for radiation therapy, radiosurgery and brachytherapy, as well
as workflow enhancing software systems across the spectrum of cancer
care.

Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer confidence to
both healthcare providers and patients, Elekta aims to improve, prolong
and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over
6,000 hospitals worldwide. Elekta employs around 3,300 employees
globally. The corporate headquarters is located in Stockholm, Sweden,
and the company is listed on the Nordic Exchange under the ticker EKTAb.

About Sunquest

Sunquest Information Systems, Inc. delivers market leading diagnostic
information technology and outreach solutions designed to fulfill the
business objectives of today's healthcare leaders. Headquartered in
Tucson, Arizona, the company has offices in Raleigh, North Carolina;
Norwich, United Kingdom; and Bangalore, India, Sunquest serves the
global marketplace with reliable technology required for mission
critical applications. These solutions provide the foundation to
optimize the healthcare experience, deliver safe, effective, and timely
patient care, expand community reach, and transform the delivery of
healthcare with predictive and personalized medicine. For more
information about Sunquest please visit www.sunquestinfo.com